| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $83.8M | +184.1% |
| Cost of Revenue | $89.4M | +166.6% |
| Gross Profit | -$5.6M | -38.3% |
| R&D Expense | $94.3M | -43.8% |
| SG&A Expense | $167.9M | +1.4% |
| Operating Income | -$270.5M | -10.7% |
| Income Tax | $70K | +155.6% |
| Net Income | -$240.7M | -13.6% |
| EPS (Basic) | -$24.84 | -1187.0% |
| EPS (Diluted) | -$24.84 | -1187.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.3M | -71.9% |
| Inventory | $65.0M | +183.7% |
| Current Assets | $154.7M | -45.1% |
| Total Assets | $460.2M | -25.7% |
| Current Liabilities | $321.5M | +60.6% |
| Total Liabilities | $491.8M | +15.8% |
| Stockholders' Equity | -$31.5M | -116.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$260.0M | -10.6% |
| Capital Expenditures | $2.6M | -38.0% |
| Investing Cash Flow | $3.9M | -97.5% |
| Financing Cash Flow | $87.5M | -55.4% |
| Free Cash Flow | -$262.6M | -9.8% |